首页>
外国专利>
Free or Liposomal Gemcitabine Alone or in Combination with Free or Liposomal Idarubicin
Free or Liposomal Gemcitabine Alone or in Combination with Free or Liposomal Idarubicin
展开▼
机译:游离或脂质体吉西他滨单独使用或与游离或脂质体依达比星联合使用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of the maximum tolerated dose (MTD) of individual drugs to determine appropriate administration ratios of drugs for combination therapy, wherein the ratios of drugs are fixed based on the same percentage of the MTD for each drug. Furthermore, antineoplastic compositions comprising liposomal encapsulated gemcitabine alone or in combination with free or liposomal encapsulated antineoplastic agents, such as idarubicin, irinotecan, etopside, cisplatin, cyclophosphamide, doxorubicin, or vincristine are diclosed.
展开▼